Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies

Clinical Transplantation

Volumn 12, Issue 5, 1998, Pages 439-444

  Vaidya, Smita ^a,b   Wang, Chu Chi ^a   Gugliuzza, Christine ^a   Fish, Jay C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIOVENOUS SHUNT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS; RISK; THROMBOCYTOPENIA; VASCULAR DISEASE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; CHILD; FEMALE; HUMANS; IMMUNOGLOBULINS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; THROMBOSIS;

EID: 0031663955     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BOWIE EJ, THOMPSON JH, PASCUZZI CA. Thrombosis in systemic lupus erythematosus despite circulating lupus anticoagulant. J Lab Clin Med 1963: 62: 416.
2. BELL WR, Boss GR, WOLFSON JS. Circulating anticoagulant in the procainamide-induced lupus syndrome. Arch Intern Med 1977: 137: 1471.
3. BICK RL. Circulating anticoagulants. In: Disorders of Thrombosis and Hemostatis: Clinical and Laboratory Practice, Chicago, ASCP Press, 1992: pp. 223.
4. ESPINOZA RL, HARTMAN RC. Significance of lupus anticoagulant. Am J Hematol 1986: 22: 331.
5. MANOUSSAKIS MN, TZIOUFAS AB, SILIS MP. High prevalence of anticardiolipin and other auto-antibodies in a healthy elderly population. Clin Exp Immunol 1987: 69: 557.
6. SHAPIRO SS, THAGARAJAN P. Lupus anticoagulants. Prog Hemostas Thromb 1982: 6: 263.
7. ZARRAKI MH, ZUCKER S. MILLER F. Immunologic and coagulation disorders in chlorpromazine treated patients. Ann Intern Med 1979: 91: 94.
8. HARRIS EN. Antiphospholipid antibodies. Br J Hematol 1990: 11: 60.
9. ROUBEY RAS. Auto-antibodies to phospholipid binding plasma proteins: a new view of lupus anticoagulant and other 'antiphospholipid' auto-antibodies. Blood 1994: 84: 2854.
10. ASHERSON RA, HARRIS EN. Anticardiolipin antibodies: clinical association. Postgrad Med J 1986: 62: 1081.
11. HUGHES GUR, HARRIS EN, GHARAVI AE. The cardiolipin syndrome. J Rheumatol 1986: 13: 486.
12. TRIPLETT DA. Clinical significance of antiphospholipid antibodies. Am Soc Clin Pathol Pres Hemostasis Thrombosis 1988: 10: 1.
13. WEIDMANN CE, WALLACE D, PETER J. Studies of IgG, IgM and IgA antiphospholipid isotypes in systemic lupus erythematosus. J Pheumatol 1988: 15: 74.
14. BRUNET P, AILLAUD MF, SAN MARCO M et al. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Int Soc Nephrol 1995:199.
15. MANDREOLI M, ZUCCHELLI P. Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol Dialys Transpl 1993: 8: 1277.
16. GARCIA-MARLIN F, DEARRIBA G, CARRASCOSA F et al. Anticardiolipin antibodies and lupus anticoagulant in endstage renal diseases. Nephrol Dial Transpl 1991: 6: 543.
17. AMIGO MC, GARCIA-TORRES R, ROBLES M et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992: 19: 1181.
18. KNIGHT RJ, SCHANZER H, RAND JH, BURROWS L. Renal allograft thrombosis associated with the antiphospholipid antibody syndrome. Transplantation 1995: 60: 614.
19. MONDRAGON-RAMERIZ G, BOCHICCHIO T, GARCIA-TORRES R et al. Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid antibody syndrome (PAPS). Clin Transplant 1994: 8: 13.
20. VAIDYA S, ORCHARD P, SCHROEDER N et al. Clinical importance of pre-mortem blood lymphocytes in cadaver donor tissue typing. Clin Transplant 1995: 9: 165.
21. Leffell MS, Bray RA. Basic principles and quality assurance of immunofluorescence and flow cytometry. In: Nikaein A, eds. American Society for Histocompatibility and Immunogenetics Laboratory Manual, 3rd edn., 1995: VI.1.
22. MORAES JR, Luo Y, MORAES ME, STASTNY P. Clinical relevance of antibodies to non-HLA antigens in organ transplantation. Clinics Lab Med 1991: 11: 3.
23. MORAES JR, Luo Y, MORAES ME, STASTNY P. Alloantibodies against donor epidermis and early transplant rejection. Transplantation 1991: 51: 370.
24. CERILLI J, BRASILE LM, GALOUZIS T, LEMPERT N, CLARKE J. The vascular endothelial cell antigen system. Transplantation 1985: 39: 286.
25. LOVELAND B, SIMPSON E. The non-MHC transplantation antigens: neither weak, nor minor. Immunology Today 1986: 7: 223.
26. SUMITRAN-KARUPPAN S, TYDEN G, REINHOLT F, BERG U, MOLLER E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transplant Immunol 1997: 5: 321.
27. BICK RL. The antiphospholipid thrombosis syndromes: facts, fictions, confusion and controversy. Am J Clin Pathol 1993: 100 (5): 677.
28. TRIPLETT DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence or cause? Arch Pathol Lab Med 1993: 117: 78.